Give me a proper definition of anemia

Reading File

Finding Sources

Reading File

I have rich, authoritative content from multiple major textbooks. Here is a thorough definition:

Anemia - Definition

Anemia is defined as a significant reduction in the volume or mass of circulating red blood cells (RBCs) in the body, relative to the normal range for a given population. Because directly measuring the total red cell mass is a complex process, clinicians rely on surrogate laboratory measures - primarily hemoglobin (Hb) concentration and hematocrit (Hct) - to identify and quantify anemia.

Goldman-Cecil Medicine: "Anemia is defined as a significant reduction in the volume of erythrocytes, or red blood cells, in the body."
Harrison's Principles of Internal Medicine (22nd ed., 2025): "Anemia is simply defined as blood counts below normal for a given population."
Frameworks for Internal Medicine: "Anemia is defined by a reduced absolute quantity of circulating red blood cells in the setting of normal plasma volume."

How It Is Measured

Measure	What It Reflects
Hemoglobin concentration (g/dL)	Directly measured; preferred in clinical practice
Hematocrit / packed cell volume (%)	Percentage of blood occupied by RBCs; approximately 3x the Hb value
RBC count (per µL)	Rarely used alone to define anemia

Because hemoglobin is directly measured (while hematocrit is a calculated value in modern analyzers), many physicians prefer Hb concentration when defining anemia. - Goldman-Cecil Medicine

Diagnostic Thresholds in Adults

Per The Washington Manual of Medical Therapeutics:

Group	Hb (g/dL)	Hct (%)
Non-pregnant women	< 12	< 36%
Men	< 13	< 39%

These thresholds vary by age, sex, race, and altitude. In children, thresholds are age-specific (defined as Hb more than 2 standard deviations below the age-specific mean). - Harriet Lane Handbook, 23rd ed.

Why It Matters Physiologically

The RBC's primary job is oxygen delivery. Hemoglobin binds O2 in the lungs and releases it to peripheral tissues. The oxygen content of arterial blood (CaO2) is described by:

CaO2 = 1.34 × [Hb] × SaO2 + (0.003 × PaO2)

A 50% drop in hemoglobin (e.g., 14 → 7 g/dL) produces a 50% reduction in CaO2, making anemia a direct threat to tissue oxygenation. By contrast, the same proportional drop in PaO2 only reduces CaO2 by ~20%. - Frameworks for Internal Medicine

Classification

Anemias are classified in two main ways:

1. By Red Cell Size (MCV):

Microcytic (low MCV): impaired hemoglobin synthesis - iron deficiency, thalassemia, anemia of chronic disease, sideroblastic anemias
Macrocytic (high MCV): impaired DNA synthesis (oval macrocytes: B12/folate deficiency, medications, myelodysplasia) or membrane defects (round macrocytes: alcohol, liver disease, hypothyroidism)
Normocytic (normal MCV): renal disease, aplastic anemia, endocrinopathies, marrow infiltration

2. By Mechanism (reticulocyte count):

Hyperproduction/Destructive (elevated reticulocytes): blood loss or hemolysis (acquired or congenital)
Underproduction (low/normal reticulocytes): nutritional deficiency, bone marrow failure, chronic disease
Harrison's Principles of Internal Medicine, 22nd ed.

All blood cells and formation with it's lineage

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Finding Sources

Reading File

I have comprehensive content from multiple authoritative textbooks and two excellent diagrams. I now have everything needed for a thorough answer.

Blood Cell Formation and Lineage (Hematopoiesis)

Overview

All blood cells originate from a single cell type - the hematopoietic stem cell (HSC) - residing in the bone marrow. This process is called hematopoiesis. Normal adult marrow contains an estimated 50,000 to 200,000 HSCs, which maintain blood cell production throughout life. - Robbins & Cotran Pathologic Basis of Disease

Sites of Hematopoiesis Through Life

Stage	Primary Site
Week 3 of embryogenesis	Yolk sac (primitive red cells, tissue macrophages)
3rd month of fetal life	Liver (chief site until near birth); also fetal placenta
4th month onward	Bone marrow (takes over, expands progressively)
Birth	All marrow spaces are active (red marrow)
After puberty	Only axial skeleton + proximal long bones; distal bones become fatty (yellow) marrow

Robbins & Cotran; Henry's Clinical Diagnosis and Management by Laboratory Methods

The Lineage Hierarchy - Full Diagram

Here is the complete hematopoietic differentiation map from Harrison's Principles of Internal Medicine (22nd ed., 2025):

Hematopoietic differentiation hierarchy showing stem cells branching into all blood cell lineages with transcription factors and cytokines labeled

And from Robbins & Cotran Pathologic Basis of Disease - a clearer CFU-based view:

Hematopoiesis diagram from Robbins showing stem cells, committed precursors (CFU-G, CFU-M, CFU-E, CFU-Mg, etc.) and mature cells

Four Levels of Maturation

Level	Description
Stem cells	Multipotent; self-renewing; give rise to all cell types
Progenitor cells	More restricted; highly proliferative (transient amplifying cells); not morphologically recognizable
Precursor cells	Committed to one lineage; morphologically recognizable (e.g., myeloblast, pronormoblast); can still divide
Mature cells	Terminally differentiated effector cells; mostly cannot divide further

Harrison's Principles of Internal Medicine, 22nd ed.

The Two Main Arms

The HSC first splits into two broad arms:

1. Common Myeloid Progenitor (CMP)

Gives rise to all non-lymphoid blood cells via sub-progenitors.

2. Common Lymphoid Progenitor (CLP)

Gives rise to all lymphoid cells.

MYELOID LINEAGE

A. Erythrocyte (Red Blood Cell) Lineage

Pathway:

HSC → CMP → Megakaryocyte-Erythroid Progenitor (MEP) → BFU-E (burst-forming unit) → CFU-E → Pronormoblast → Basophilic normoblast → Polychromatophilic normoblast → Orthochromatic normoblast → Reticulocyte → Mature RBC

Key regulator: Erythropoietin (EPO), produced by the kidney in response to hypoxia. Transcription factors: GATA1, SCL

Normoblastic maturation stages (Henry's Clinical Diagnosis):

Stage	Size	Key Features
Pronormoblast	~20 µm (largest)	Fine chromatin, prominent nucleolus, basophilic cytoplasm, no granules
Basophilic normoblast	Smaller	Coarser clumped chromatin, deeply basophilic cytoplasm (rich in RNA/ribosomes)
Polychromatophilic normoblast	Smaller	Cytoplasm turns gray-blue as hemoglobin accumulates; nucleus occupies ~50%
Orthochromatic normoblast	Smaller	Pyknotic (dense, small) nucleus; cytoplasm near-pink; no more mitosis
Reticulocyte	Slightly larger than RBC	Nucleus extruded; residual RNA/mitochondria remain; stays 1-2 days in marrow, 1 day in blood
Mature RBC (Erythrocyte)	~7-8 µm	Anucleate biconcave disc; lives ~120 days

One pronormoblast generates up to 16 reticulocytes through 3-4 mitotic divisions over 3 days. Developing erythroid cells cluster around macrophages in erythroblastic islands where iron is transferred for hemoglobin synthesis.

B. Granulocyte Lineage (Neutrophil, Eosinophil, Basophil)

Pathway:

HSC → CMP → Granulocyte-Monocyte Progenitor (GMP) → Granulocyte Progenitor → Myeloblast → Promyelocyte → Myelocyte → Metamyelocyte → Band form → Mature Granulocyte

Sub-lineages from the Granulocyte Progenitor:

CFU-G → Neutrophil (regulated by G-CSF; transcription factor C/EBPα)
CFU-eo → Eosinophil (regulated by IL-5; transcription factor C/EBPε)
CFU-b → Basophil / Mast cell (regulated by IL-3, SCF)

Neutrophil is the most abundant granulocyte. Mature granulocytes cannot proliferate - numbers can only increase via production from precursors.

C. Monocyte / Macrophage Lineage

Pathway:

HSC → CMP → GMP → Monocyte Progenitor → Monoblast → Promonocyte → Monocyte (blood) → Macrophage (tissue)

Regulator: M-CSF (macrophage colony-stimulating factor) Transcription factors: Egn1, Myb

Monocytes circulate briefly in blood (~1-3 days) then enter tissues and differentiate into tissue macrophages (e.g., Kupffer cells in liver, microglial cells in brain, alveolar macrophages in lung, osteoclasts in bone).

Dendritic cells (both monocytoid and plasmacytoid types) also arise from this progenitor pool, regulated by FLT-3 Ligand.

D. Megakaryocyte / Platelet Lineage

Pathway:

HSC → CMP → MEP → Megakaryoblast → Promegakaryocyte → Megakaryocyte → shedding of cytoplasm into Platelets

Regulator: Thrombopoietin (TPO) Transcription factors: Fli-1, AML-1

Megakaryocytes are giant cells in the marrow that undergo endomitosis (DNA replication without cell division), becoming polyploid. They then extend long cytoplasmic processes called proplatelets through the marrow sinusoidal wall, from which platelets are pinched off into the bloodstream. Each megakaryocyte produces ~1,000-3,000 platelets. Platelets live ~7-10 days and are anucleate.

LYMPHOID LINEAGE

Pathway:

HSC → Common Lymphoid Progenitor (CLP) → three sub-lineages:

Lineage	Progenitor	Mature Cell	Key Regulator	Transcription Factor
B cells	Pro-B → Pre-B	B lymphocyte → Plasma cell	IL-7, IL-4	LEF1, E2A, EBF, PAX-5
T cells	Pro-T → Pre-T (matures in thymus)	T lymphocyte (CD4+ helper, CD8+ cytotoxic)	IL-7, IL-2	NOTCH1, IKAROS, GATA3
NK cells	T/NK progenitor → NK progenitor	Natural killer cell	IL-7, IL-15	Id2, Ets-1
Plasmacytoid Dendritic cells	Direct from CLP	pDC	FLT-3 Ligand	-

B cells mature entirely in the bone marrow. T cells complete their maturation in the thymus (positive and negative selection). NK cells are innate lymphoid cells that do not require antigen-specific activation.

Harrison's Principles of Internal Medicine, 22nd ed.

Key Cytokines and Growth Factors Summary

Factor	Primary Target
EPO (erythropoietin)	Erythrocyte production
TPO (thrombopoietin)	Megakaryocyte / platelet production
G-CSF	Neutrophil production and mobilization
M-CSF	Monocyte / macrophage production
GM-CSF	Granulocyte + monocyte progenitors
IL-3	Multi-lineage progenitor support
IL-4	B-cell differentiation
IL-5	Eosinophil production
IL-7	Lymphoid progenitors (B and T cells)
IL-15	NK cell development
SCF (stem cell factor)	HSC and early progenitors
FLT-3 Ligand	Dendritic cells, early progenitors

Summary Tree (Text Form)

Hematopoietic Stem Cell (HSC)
├── Common Myeloid Progenitor (CMP)
│   ├── Granulocyte-Monocyte Progenitor (GMP)
│   │   ├── CFU-G → Neutrophil
│   │   ├── CFU-eo → Eosinophil
│   │   ├── CFU-b → Basophil / Mast cell
│   │   └── Monocyte Progenitor → Monocyte → Macrophage / Dendritic cell
│   └── Megakaryocyte-Erythroid Progenitor (MEP)
│       ├── CFU-E → Pronormoblast → ... → Erythrocyte (RBC)
│       └── CFU-Mg → Megakaryoblast → Megakaryocyte → Platelets
└── Common Lymphoid Progenitor (CLP)
    ├── Pro-B → Pre-B → B cell → Plasma cell
    ├── Pro-T → Pre-T → T cell (CD4+/CD8+) [matures in thymus]
    ├── T/NK Progenitor → NK cell
    └── Plasmacytoid Dendritic cell

Sources: Harrison's Principles of Internal Medicine 22E (2025); Robbins, Cotran & Kumar Pathologic Basis of Disease; Henry's Clinical Diagnosis and Management by Laboratory Methods

This is a shared conversation. Sign in to Orris to start your own chat.